FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Scott Wilbur

Research Profile

Living Beings

Chemicals & Drugs

Procedures

Concepts & Ideas

Tissue Distribution

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Johnnie J Orozco; Oliver W Press; D Scott Wilbur; Tom Bäck; Ethan R Balkin; Darrell R Fisher; Shani L Frayo; Ajay K Gopal; Damian J Green; Donald K Hamlin; Mark Hylarides; Aimee Kenoyer; John M Pagel
Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.
D Scott Wilbur
Enigmatic astatine.
D Scott Wilbur; Erlinda B Santos; Yun Chen; Ming-Kuan Chyan; Donald K Hamlin; Brian T Kornblit; Hirohisa Nakamae; Brenda M Sandmaier
Reagents for astatination of biomolecules. 6. An intact antibody conjugated with a maleimido-closo-decaborate(2-) reagent via sulfhydryl groups had considerably higher kidney concentrations than the same antibody conjugated with an isothiocyanato-closo-decaborate(2-) reagent via lysine amines.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Scott Wilbur (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Johnnie J Orozco; Oliver W Press; D Scott Wilbur; Tom Bäck; Ethan R Balkin; Darrell R Fisher; Shani L Frayo; Ajay K Gopal; Damian J Green; Donald K Hamlin; Mark Hylarides; Aimee Kenoyer; John M Pagel
Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.
Blood 2013;121(18):3759-67.
2013: D Scott Wilbur
Enigmatic astatine.
Nature chemistry 2013;5(3):246.
2012: D Scott Wilbur; Erlinda B Santos; Yun Chen; Ming-Kuan Chyan; Donald K Hamlin; Brian T Kornblit; Hirohisa Nakamae; Brenda M Sandmaier
Reagents for astatination of biomolecules. 6. An intact antibody conjugated with a maleimido-closo-decaborate(2-) reagent via sulfhydryl groups had considerably higher kidney concentrations than the same antibody conjugated with an isothiocyanato-closo-decaborate(2-) reagent via lysine amines.
Bioconjugate chemistry 2012;23(3):409-20.
2012: Yun Chen; Donald K Hamlin; Brian Kornblit; George E Sale; Erlinda B Santos; Rainer Storb; Barry E Storer; D Scott Wilbur; Brenda M Sandmaier
Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.
Blood 2012;119(5):1130-8.
2011: John M Pagel; Steven I Park; Jaideep Shenoi; D Scott Wilbur; Frederick R Appelbaum; Amanda Axtman; Tom Bäck; Darrell R Fisher; Shani Frayo; Ajay K Gopal; Damian J Green; Donald K Hamlin; Aimee L Kenoyer; Yukang Lin; Nural Orgun; Johnnie Orozco; Oliver W Press
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.
Blood 2011;118(3):703-11.
2010: Steven I Park; Jaideep Shenoi; John M Pagel; Don K Hamlin; D Scott Wilbur; Nural Orgun; Aimee L Kenoyer; Shani Frayo; Amanda Axtman; Tom Bäck; Yukang Lin; Darrell R Fisher; Ajay K Gopal; Damian J Green; Oliver W Press
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.
Blood 2010;116(20):4231-9.
2010: Hirohisa Nakamae; Fabio R Kerbauy; D Scott Wilbur; Wolfgang A Bethge; Donald K Hamlin; Erlinda B Santos; Rainer Storb; Brenda M Sandmaier
Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation.
Transplantation 2010;89(11):1336-40.
2010: D Scott Wilbur; Ming-Kuan Chyan; Donald K Hamlin; Matthew A Perry
Preparation and in vivo evaluation of radioiodinated closo-decaborate(2-) derivatives to identify structural components that provide low retention in tissues.
Nuclear medicine and biology 2010;37(2):167-78.
2009: D Scott Wilbur; Monica S Thakar; Donald K Hamlin; Erlinda B Santos; Ming-Kuan Chyan; Hirohisa Nakamae; John M Pagel; Oliver W Press; Brenda M Sandmaier
Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine.
Bioconjugate chemistry 2009;20(10):1983-91.
2009: Damian J Green; John M Pagel; Eneida R Nemecek; Yukang Lin; Aimee Kenoyer; Anastasia Pantelias; Donald K Hamlin; D Scott Wilbur; Darrell R Fisher; Joseph G Rajendran; Ajay K Gopal; Steven Park; Oliver W Press
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.
Blood 2009;114(6):1226-35.
2009: John M Pagel; Nural Orgun; Donald K Hamlin; D Scott Wilbur; Theodore A Gooley; Ajay K Gopal; Steven Park; Damian J Green; Yukang Lin; Oliver W Press
A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.
Blood 2009;113(20):4903-13.
2009: D Scott Wilbur; Ming-Kuan Chyan; Donald K Hamlin; Matthew A Perry
Reagents for astatination of biomolecules. 3. Comparison of closo-decaborate(2-) and closo-dodecaborate(2-) moieties as reactive groups for labeling with astatine-211.
Bioconjugate chemistry 2009;20(3):591-602.
2009: Hirohisa Nakamae; D Scott Wilbur; Donald K Hamlin; Monica S Thakar; Erlinda B Santos; Darrell R Fisher; Aimee L Kenoyer; John M Pagel; Oliver W Press; Rainer Storb; Brenda M Sandmaier
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211.
Cancer research 2009;69(6):2408-15.
2009: John M Pagel; Dana C Matthews; Aimee Kenoyer; Donald K Hamlin; D Scott Wilbur; Darrell R Fisher; Ajay K Gopal; Yukang Lin; Laura Saganic; Frederick R Appelbaum; Oliver W Press
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.
Cancer research 2009;69(1):185-92.
2008: John M Pagel; Nathan Hedin; Lacey Drouet; Brent L Wood; Anastasia Pantelias; Yukang Lin; Donald K Hamlin; D Scott Wilbur; Ajay K Gopal; Damian Green; Frederick R Appelbaum; Oliver W Press
Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.
Blood 2008;111(4):2261-8.
2008: D Scott Wilbur; Donald K Hamlin; Ming-Kuan Chyan; Martin W Brechbiel
Streptavidin in antibody pretargeting. 5. chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides 213Bi and 211At.
Bioconjugate chemistry 2008;19(1):158-70.
2007: Damian J Green; John M Pagel; Anastasia Pantelias; Nathan Hedin; Yukang Lin; D Scott Wilbur; Ajay K Gopal; Donald K Hamlin; Oliver W Press
Pretargeted radioimmunotherapy for B-cell lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5598s-5603s.
2007: Keith B Hartman; Donald K Hamlin; D Scott Wilbur; Lon J Wilson
211AtCl@US-tube nanocapsules: a new concept in radiotherapeutic-agent design.
Small (Weinheim an der Bergstrasse, Germany) 2007;3(9):1496-9.
2007: D Scott Wilbur; Ming-Kuan Chyan; Donald K Hamlin; Robert L Vessella; Timothy J Wedge; M Frederick Hawthorne
Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Bioconjugate chemistry 2007;18(4):1226-40.
2007: John M Pagel; Anastasia Pantelias; Nathan Hedin; Shani Wilbur; Laura Saganic; Yukang Lin; Axworthy Don; Donald K Hamlin; D Scott Wilbur; Ajay K Gopal; Oliver W Press
Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas.
Cancer research 2007;67(12):5921-8.
2007: Anastasia Pantelias; John M Pagel; Nathan Hedin; Laura Saganic; Shani Wilbur; Donald K Hamlin; D Scott Wilbur; Yukang Lin; Diane Stone; Axworthy Don; Ajay K Gopal; Oliver W Press
Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas.
Blood 2007;109(11):4980-7.
2007: Ann-Charlott Steffen; Ylva Almqvist; Ming-Kuan Chyan; Hans Lundqvist; Vladimir Tolmachev; D Scott Wilbur; Jörgen Carlsson
Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
Oncology reports 2007;17(5):1141-7.
2006: D Scott Wilbur; Donald K Hamlin; Ming-Kuan Chyan
Biotin reagents for antibody pretargeting. 7. Investigation of chemically inert biotinidase blocking functionalities for synthetic utility.
Bioconjugate chemistry 2006;17(6):1514-22.
2006: Wolfgang A Bethge; D Scott Wilbur; Brenda M Sandmaier
Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation.
Leukemia & lymphoma 2006;47(7):1205-14.
2006: John M Pagel; Yukang Lin; Nathan Hedin; Anastasia Pantelias; Axworthy Don; Diane Stone; Donald K Hamlin; D Scott Wilbur; Oliver W Press
Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas.
Blood 2006;108(1):328-36.
2005: Michael J Adam; D Scott Wilbur
Radiohalogens for imaging and therapy.
Chemical Society reviews 2005;34(2):153-63.
2005: Kevin J Hamblett; Oliver W Press; Damon L Meyer; Donald K Hamlin; Axworthy Don; D Scott Wilbur; Patrick S Stayton
Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma.
Bioconjugate chemistry 2005;16(1):131-8.
2004: D Scott Wilbur; Donald K Hamlin; James Sanderson; Yukang Lin
Streptavidin in antibody pretargeting. 4. Site-directed mutation provides evidence that both arginine and lysine residues are involved in kidney localization.
Bioconjugate chemistry 2004;15(6):1454-63.
2004: Wolfgang A Bethge; D Scott Wilbur; Rainer Storb; Donald K Hamlin; Erlinda B Santos; Martin W Brechbiel; Brenda M Sandmaier
Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study.
Transplantation 2004;78(3):352-9.
2004: D Scott Wilbur; Donald K Hamlin; Ming-Kuan Chyan; Brian B Kegley; Janna Quinn; Robert L Vessella
Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives.
Bioconjugate chemistry 2004;15(3):601-16.
2004: D Scott Wilbur; Donald K Hamlin; Rajiv R Srivastava; Ming-Kuan Chyan
Synthesis, radioiodination, and biodistribution of some nido- and closo-monocarbon carborane derivatives.
Nuclear medicine and biology 2004;31(4):523-30.
2004: D Scott Wilbur; Ming-Kuan Chyan; Donald K Hamlin; Brian B Kegley; Reudi Risler; Pradip M Pathare; Janna Quinn; Robert L Vessella; Catherine Foulon; Michael R Zalutsky; Timothy J Wedge; M Frederick Hawthorne
Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds.
Bioconjugate chemistry 2004;15(1):203-23.
2003: Wolfgang A Bethge; D Scott Wilbur; Rainer Storb; Donald K Hamlin; Erlinda B Santos; Martin W Brechbiel; Darrell R Fisher; Brenda M Sandmaier
Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation.
Blood 2003;101(12):5068-75.
2003: John M Pagel; Nathan Hedin; Krishnan Subbiah; Damon Meyer; Robert Mallet; Axworthy Don; Louis J Theodore; D Scott Wilbur; Dana C Matthews; Oliver W Press
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.
Blood 2003;101(6):2340-8.
2003: Krishnan Subbiah; Donald K Hamlin; John M Pagel; D Scott Wilbur; Damon L Meyer; Axworthy Don; Robert W Mallett; Louis J Theodore; Patrick S Stayton; Oliver W Press
Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(3):437-45.
2002: D Scott Wilbur; Ming-Kuan Chyan; Donald K Hamlin; Brian B Kegley; Rune Nilsson; Bengt E B Sandberg; Martin W Brechbiel
Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies.
Bioconjugate chemistry 2002;13(5):1079-92.
2002: Brenda M Sandmaier; Wolfgang A Bethge; D Scott Wilbur; Donald K Hamlin; Erlinda B Santos; Martin W Brechbiel; Darrell R Fisher; Rainer Storb
Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.
Blood 2002;100(1):318-26.
2002: D Scott Wilbur; Donald K Hamlin; Damon L Meyer; Robert W Mallett; Janna Quinn; Robert L Vessella; Oliver W Press
Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.
Bioconjugate chemistry 2002;13(3):611-20.
2002: Kevin J Hamblett; Brian B Kegley; Donald K Hamlin; Ming-Kuan Chyan; David E Hyre; Oliver W Press; D Scott Wilbur; Patrick S Stayton
A streptavidin-biotin binding system that minimizes blocking by endogenous biotin.
Bioconjugate chemistry 2002;13(3):588-98.
2001: Oliver W Press; M Corcoran; Krishnan Subbiah; Donald K Hamlin; D Scott Wilbur; T Johnson; Louis J Theodore; E Yau; Robert W Mallett; Damon L Meyer; Axworthy Don
A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts.
Blood 2001;98(8):2535-43.
2001: D Scott Wilbur
Overcoming the obstacles to clinical evaluation of (211)At-labeled radiopharmaceuticals.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(10):1516-8.
2001: D Scott Wilbur; Donald K Hamlin; Ming-Kuan Chyan; Brian B Kegley; Pradip M Pathare
Biotin reagents for antibody pretargeting. 5. Additional studies of biotin conjugate design to provide biotinidase stability.
Bioconjugate chemistry 2001;12(4):616-23.
2000: D Scott Wilbur; Pradip M Pathare; Donald K Hamlin; M B Frownfelter; Brian B Kegley; Wai-Yee Leung; K R Gee
Evaluation of biotin-dye conjugates for use in an HPLC assay to assess relative binding of biotin derivatives with avidin and streptavidin.
Bioconjugate chemistry 2000;11(4):584-98.
2000: D Scott Wilbur; Ming-Kuan Chyan; Pradip M Pathare; Donald K Hamlin; M B Frownfelter; Brian B Kegley
Biotin reagents for antibody pretargeting. 4. Selection of biotin conjugates for in vivo application based on their dissociation rate from avidin and streptavidin.
Bioconjugate chemistry 2000;11(4):569-83.
1999: D Scott Wilbur; Pradip M Pathare; Donald K Hamlin; Patrick S Stayton; Richard To; Lisa A Klumb; Kent R Buhler; Robert L Vessella
Development of new biotin/streptavidin reagents for pretargeting.
Biomolecular engineering 1999;16(1-4):113-8.
1999: D Scott Wilbur; Pradip M Pathare; Donald K Hamlin; Sheldon P Rothenberg; Edward V Quadros
Radioiodination of cyanocobalamin conjugates containing hydrophilic linkers: preparation of a radioiodinated cyanocobalamin monomer and two dimers, and assessment of their binding with transcobalamin II.
Bioconjugate chemistry 1999;10(5):912-20.
1998: D Scott Wilbur; Pradip M Pathare; Donald K Hamlin; Kent R Buhler; Robert L Vessella
Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers.
Bioconjugate chemistry 1998;9(6):813-25.
1998: P H Tan; V Chu; JE Stray; Donald K Hamlin; DK Pettit; D Scott Wilbur; Robert L Vessella; Patrick S Stayton
Engineering the isoelectric point of a renal cell carcinoma targeting antibody greatly enhances scFv solubility.
Immunotechnology : an international journal of immunological engineering 1998;4(2):107-14.
1998: D Scott Wilbur; Donald K Hamlin; Kent R Buhler; Pradip M Pathare; Robert L Vessella; Patrick S Stayton; Richard To
Streptavidin in antibody pretargeting. 2. Evaluation Of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacity.
Bioconjugate chemistry 1998;9(3):322-30.
1998: D Scott Wilbur; Patrick S Stayton; Richard To; Kent R Buhler; Lisa A Klumb; Donald K Hamlin; JE Stray; Robert L Vessella
Streptavidin in antibody pretargeting. Comparison of a recombinant streptavidin with two streptavidin mutant proteins and two commercially available streptavidin proteins.
Bioconjugate chemistry 1998;9(1):100-7.
1997: D Scott Wilbur; Pradip M Pathare; Donald K Hamlin; S A Weerawarna
Biotin reagents for antibody pretargeting. 2. Synthesis and in vitro evaluation of biotin dimers and trimers for cross-linking of streptavidin.
Bioconjugate chemistry 1997;8(6):819-32.
1997: Graeme McLean; Pradip M Pathare; D Scott Wilbur; AC Morgan; Clive Woodhouse; John W Schrader; Hermann J Ziltener
Cobalamin analogues modulate the growth of leukemia cells in vitro.
Cancer research 1997;57(18):4015-22.
1997: D Scott Wilbur; Donald K Hamlin; Pradip M Pathare; S A Weerawarna
Biotin reagents for antibody pretargeting. Synthesis, radioiodination, and in vitro evaluation of water soluble, biotinidase resistant biotin derivatives.
Bioconjugate chemistry 1997;8(4):572-84.
1997: Pradip M Pathare; D Scott Wilbur; Donald K Hamlin; S Heusser; Edward V Quadros; P McLoughlin; AC Morgan
Synthesis of cobalamin dimers using isophthalate cross-linking of corrin ring carboxylates and evaluation of their binding to transcobalamin II.
Bioconjugate chemistry 1997;8(2):161-72.
1996: D Scott Wilbur; Donald K Hamlin; Robert L Vessella; JE Stray; Kent R Buhler; Patrick S Stayton; Lisa A Klumb; Pradip M Pathare; S A Weerawarna
Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
Bioconjugate chemistry 1996;7(6):689-702.
1996: D Scott Wilbur; Donald K Hamlin; Pradip M Pathare; S Heusser; Robert L Vessella; Kent R Buhler; JE Stray; J Daniel; Edward V Quadros; P McLoughlin; AC Morgan
Synthesis and nca-radioiodination of arylstannyl-cobalamin conjugates. Evaluation of aryliodo-cobalamin conjugate binding to transcobalamin II and biodistribution in mice.
Bioconjugate chemistry 1996;7(4):461-74.
1996: Pradip M Pathare; D Scott Wilbur; S Heusser; Edward V Quadros; P McLoughlin; AC Morgan
Synthesis of cobalamin-biotin conjugates that vary in the position of cobalamin coupling. Evaluation of cobalamin derivative binding to transcobalamin II.
Bioconjugate chemistry 1996;7(2):217-32.
1996: George E Laramore; Ruedi Risler; TW Griffin; P Wootton; D Scott Wilbur
Fast neutron radiotherapy and boron neutron capture therapy: application to a human melanoma test system.
Bulletin du cancer. Radiothérapie : journal de la Société française du cancer : organe de la société française de radiothérapie oncologique 1996;83 Suppl():191s-7s.
1994: D Scott Wilbur; Donald K Hamlin; John Livesey; R R Srivastava; George E Laramore; TW Griffin
Synthesis and radioiodination of a nido-1,2-carboranyl derivative of 2-nitroimidazole.
Nuclear medicine and biology 1994;21(4):601-11.
1994: D Scott Wilbur; JE Stray; Donald K Hamlin; D K Curtis; Robert L Vessella
Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
Bioconjugate chemistry 1994;5(3):220-35.
1994: George E Laramore; P Wootton; John Livesey; D Scott Wilbur; Ruedi Risler; M Phillips; J Jacky; Thomas Buchholz; TW Griffin; S Brossard
Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy.
International journal of radiation oncology, biology, physics 1994;28(5):1135-42.
1994: Thomas Buchholz; George E Laramore; P Wootton; John Livesey; D Scott Wilbur; Ruedi Risler; M Phillips; J Jacky; TW Griffin
Enhancement of fast neutron beams with boron neutron capture therapy. A mechanism for achieving a selective, concomitant tumor boost.
Acta oncologica (Stockholm, Sweden) 1994;33(3):307-13.
1993: D Scott Wilbur; Donald K Hamlin; R R Srivastava; H Donald Burns
Synthesis and radioiodination of N-Boc-p-(tri-n-butylstannyl)-L-phenylalanine tetrafluorophenyl ester: preparation of a radiolabeled phenylalanine derivative for peptide synthesis.
Bioconjugate chemistry 1993;4(6):574-80.
1993: D Scott Wilbur; Robert L Vessella; JE Stray; D K Goffe; K A Blouke; R W Atcher
Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab')2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab')2.
Nuclear medicine and biology 1993;20(8):917-27.
1992: D Scott Wilbur
Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling.
Bioconjugate chemistry 1992;3(6):433-70.
1991: M D Hylarides; D Scott Wilbur; M W Reed; S W Hadley; J R Schroeder; L M Grant
Preparation and in vivo evaluation of an N-(p-[125I]iodophenethyl)maleimide-antibody conjugate.
Bioconjugate chemistry 1991;2(6):435-40.
1991: S W Hadley; D Scott Wilbur; M A Gray; R W Atcher
Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate.
Bioconjugate chemistry 1991;2(3):171-9.
1991: D Scott Wilbur; S W Hadley; L M Grant; M D Hylarides
Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab.
Bioconjugate chemistry 1991;2(2):111-6.
1991: D Scott Wilbur; M D Hylarides
Radiolabeling of a monoclonal antibody with N-succinimidyl para-[77Br]bromobenzoate.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(3):363-5.
1990: S W Hadley; D Scott Wilbur
Evaluation of iodovinyl antibody conjugates: comparison with a p-iodobenzoyl conjugate and direct radioiodination.
Bioconjugate chemistry 1990;1(2):154-61.
1990: C C Badger; D Scott Wilbur; S W Hadley; A R Fritzberg; Irwin D Bernstein
Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in a murine lymphoma model.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(4):381-7.
1989: D Scott Wilbur; S W Hadley; M D Hylarides; P G Abrams; P A Beaumier; AC Morgan; JM Reno; A R Fritzberg
Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(2):216-26.
1989: Janet F Eary; R W Schroff; P G Abrams; A R Fritzberg; AC Morgan; S Kasina; JM Reno; A Srinivasan; Clive Woodhouse; D Scott Wilbur
Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(1):25-32.
1988: A R Fritzberg; P G Abrams; P L Beaumier; S Kasina; AC Morgan; T N Rao; JM Reno; J A Sanderson; A Srinivasan; D Scott Wilbur
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(11):4025-9.
1983: M D Hylarides; D Scott Wilbur; F A Mettler
B-ring aromatization of estrogen derivatives.
Steroids 1983;41(5):657-62.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.